Icosavax Inc. (ICVX)
NASDAQ: ICVX
· Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM
Icosavax Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | -5.73M | -3.9M | -2M | n/a | 5.73M | 3.9M | 2M |
Cost of Revenue | 3.67M | 3.05M | 2.39M | 1.75M | 143K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -3.67M | -3.05M | -2.39M | -1.75M | -5.88M | -3.9M | -2M | n/a | 5.73M | 3.9M | 2M |
Operating Income | -105.88M | -103.75M | -97.93M | -95.06M | -88.14M | -99.41M | -84.87M | -65.86M | -52.16M | -23.21M | -19.82M |
Interest Income | 9.17M | 7.1M | 5.14M | 3.3M | 1.81M | 644K | 149K | 29K | n/a | n/a | n/a |
Pretax Income | -96.71M | -96.65M | -92.79M | -91.76M | -86.33M | -98.74M | -84.65M | -66.97M | -53.4M | -24.59M | -21.23M |
Net Income | -92.62M | -91.39M | -87.03M | -87.84M | -84.55M | -98.12M | -84.53M | -66.97M | -53.4M | -24.59M | -21.23M |
Selling & General & Admin | 35.84M | 34.89M | 33.07M | 30.23M | 27.51M | 45.21M | 40.12M | 34.89M | 29.47M | 4.82M | 3.14M |
Research & Development | 70.04M | 68.86M | 64.85M | 65.41M | 63.28M | 58.68M | 51.14M | 38.78M | 30.04M | 23.91M | 20.3M |
Other Expenses | 582K | 582K | 582K | n/a | -582K | -582K | -582K | -205K | -1.82M | -1.82M | -1.82M |
Operating Expenses | 105.88M | 103.75M | 97.93M | 95.06M | 88.14M | 99.41M | 84.87M | 65.86M | 52.16M | 23.21M | 19.82M |
Interest Expense | n/a | 1.17M | 1.17M | 1.29M | 1.29M | 147K | 189K | 318K | 318K | 291K | 249K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 105.88M | 103.75M | 97.93M | 95.06M | 88.14M | 99.41M | 84.87M | 65.86M | 52.16M | 23.21M | 19.82M |
Income Tax Expense | -4.09M | -5.26M | -5.76M | -3.92M | -1.78M | -615K | -120K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 50.03M | 44.77M | 41.26M | 39.81M | 39.75M | 39.59M | 39.4M | 39.14M | 26.49M | 2.99M | 2.99M |
Shares Outstanding (Diluted) | 50.03M | 44.77M | 41.26M | 39.81M | 39.75M | 39.59M | 39.4M | 39.14M | 26.49M | 2.99M | 2.99M |
EPS (Basic) | -2.12 | -2.2 | -2.17 | -2.21 | -2.13 | -2.91 | -5.21 | -6.58 | -7.72 | -8.29 | -7.17 |
EPS (Diluted) | -2.12 | -2.2 | -2.17 | -2.21 | -2.13 | -2.91 | -5.21 | -6.58 | -7.72 | -8.29 | -7.17 |
EBITDA | -105.88M | -103.61M | -97.73M | -94.82M | -87.9M | -99.28M | -84.78M | -65.81M | -52.12M | -23.19M | -19.82M |
EBIT | -50.95M | -71.76M | -94.89M | -93.1M | -85.66M | -99.21M | -84.59M | -66.78M | -53.36M | -24.46M | -21.15M |
Depreciation & Amortization | 2.69M | 2.07M | 1.46M | 860K | 277K | 163K | 124K | 82K | 47K | 70.75K | 105.87K |